GlassScriptPhysician profile
Kevin Jiang
NPI 1134480510
$2,963.89
in general payments reported to CMS, 2019-2025
16 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $168 · 2021: $379 · 2022: $632 · 2023: $1,013 · 2024: $112 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $705 · Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $705.00 |
| Food and Beverage | $661.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $785.07 | 2021-2023 | Ensite Precision |
| Ibsa Pharma INC. | $708.37 | 2021-2024 | Tirosint, Licart, Licart |
| Boston Scientific Corporation | $561.39 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $178.34 | 2019-2020 | |
| Nalu Medical, INC. | $160.32 | 2021-2025 | Nalu Neurostimulation System |
| Depuy Synthes Sales INC. | $152.89 | 2022-2025 | Trumatch, Matrixmandible |
| Abbvie INC. | $93.37 | 2023-2024 | |
| Grt US Holding, INC. | $71.03 | 2021-2022 | |
| Bioventus LLC | $52.33 | 2022-2023 | Durolane |
| Collegium Pharmaceutical, INC. | $38.50 | 2019 | |
| Horizon Therapeutics Plc | $38.06 | 2023 | Tepezza |
| Virtus Pharmaceuticals LLC | $35.60 | 2021 | |
| Medtronic, INC. | $24.97 | 2023 | Intellis Adaptivestim |
| Ethicon US, LLC | $22.46 | 2025 | Dermabond Prineo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.88 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.